Infectious Disease · ICMR

Extrapulmonary tuberculosis

ICMR

Source:Index-TB Guidelines for Extrapulmonary TB (2022)NTEP Technical Operational Guidelines (2022)WHO Consolidated Guidelines on TB Treatment 2022

Verified Apr 2026

Ask House about this guideline

Red Flags

Tubercular meningitis with raised intracranial pressure or hydrocephalus — neurosurgical evaluation; corticosteroids alongside ATT^[1]
Spinal TB (Pott's spine) with neurological deficit — emergency surgical decompression plus ATT^[1]
Miliary TB with respiratory failure or CNS involvement — admit; ICU; ATT plus high-dose corticosteroids; rule out HIV^[1]
TB pericarditis with cardiac tamponade — emergency pericardiocentesis; ATT plus corticosteroids^[1]

First-line treatment

Interventions

Directly observed treatment (DOT)^[1]
All ATT under DOT (in-person or video) per NTEP; family or treatment supporter validated
Surgical involvement for selected sites^[1]
Pott's spine with deficit — decompression; lymph node abscess — drainage; pericardial effusion with tamponade — pericardiocentesis

First-line drug therapy

Drug	Class	Adult	Paediatric	Notes
HRZE (isoniazid + rifampicin + pyrazinamide + ethambutol)^[1]	First-line antitubercular fixed-dose combination	Weight-band: 30–37 kg: 2 FDC tabs; 38–54: 3 tabs; 55–69: 4 tabs; ≥70: 5 tabs daily for intensive phase	Weight-band per NTEP paediatric tables	Standard 6-month regimen for most extrapulmonary TB (2HRZE / 4HR). Extended to 9–12 months for CNS, bone, joint, disseminated TB
Pyridoxine (vitamin B6)^[1]	Adjunctive co-prescription	10 mg PO daily during ATT	5–10 mg daily	Prevents isoniazid-induced peripheral neuropathy
Dexamethasone (TBM and TB pericarditis)^[1]	Glucocorticoid adjunct	TBM: dexamethasone 0.4 mg/kg/day IV tapering over 6–8 weeks. TB pericarditis: prednisolone 60 mg/day for 4 weeks then taper	0.3 mg/kg/day (TBM)	Reduces mortality in TBM and prevents constriction in pericarditis
MDR/XDR-TB regimen (BPaL/BPaLM)^[2]	All-oral shorter regimen for MDR-TB	Bedaquiline + pretomanid + linezolid (± moxifloxacin) for 6 months per WHO 2024 update	—	Specialist (programmatic management of drug-resistant TB) only. DST-driven; shorter than 18-month regimens

HRZE (isoniazid + rifampicin + pyrazinamide + ethambutol)^[1]

First-line antitubercular fixed-dose combination

Adult: Weight-band: 30–37 kg: 2 FDC tabs; 38–54: 3 tabs; 55–69: 4 tabs; ≥70: 5 tabs daily for intensive phase
Paediatric: Weight-band per NTEP paediatric tables

Standard 6-month regimen for most extrapulmonary TB (2HRZE / 4HR). Extended to 9–12 months for CNS, bone, joint, disseminated TB

Pyridoxine (vitamin B6)^[1]

Adjunctive co-prescription

Adult: 10 mg PO daily during ATT
Paediatric: 5–10 mg daily

Prevents isoniazid-induced peripheral neuropathy

Dexamethasone (TBM and TB pericarditis)^[1]

Glucocorticoid adjunct

Adult: TBM: dexamethasone 0.4 mg/kg/day IV tapering over 6–8 weeks. TB pericarditis: prednisolone 60 mg/day for 4 weeks then taper
Paediatric: 0.3 mg/kg/day (TBM)

Reduces mortality in TBM and prevents constriction in pericarditis

MDR/XDR-TB regimen (BPaL/BPaLM)^[2]

All-oral shorter regimen for MDR-TB

Adult: Bedaquiline + pretomanid + linezolid (± moxifloxacin) for 6 months per WHO 2024 update
Paediatric: —

Specialist (programmatic management of drug-resistant TB) only. DST-driven; shorter than 18-month regimens

Safety-net

Take ATT every day even when feeling well — interruption causes resistance and relapse; full course is essential^[1]
Watch for jaundice, severe vomiting, vision changes, or numb hands/feet during ATT — same-day medical review (drug toxicity)^[1]
Tell your dentist, surgeon, or any other doctor that you are on ATT — drug interactions are common (especially with rifampicin)^[1]

Referral criteria

TB meningitis or spinal TB with neurological deficitNeurology / neurosurgery and ID urgently^[1]
Drug-resistant TB (rifampicin-resistant on Xpert, MDR/XDR)Programmatic Management of Drug-Resistant TB (PMDT) centre^[2]
Treatment failure or relapseTB specialist for re-evaluation and DST^[1]
Severe ATT-related hepatitis (ALT >3× ULN with symptoms or >5× without)Hospital admission; pause ATT; sequential reintroduction under supervision^[1]

Clinical summary

Diagnosis and treatment of extrapulmonary TB (lymph node, pleural, abdominal, CNS, bone, miliary); longer durations for CNS, bone, and disseminated disease.

References

1.Index-TB Guidelines for Extrapulmonary TB; NTEP Technical Operational Guidelines (2022); WHO Consolidated Guidelines on TB Treatment 2022 (2022)
2.WHO Consolidated Guidelines on Tuberculosis: Drug-Resistant TB Treatment, 2024 Update. WHO, Geneva (2024)

Drug

Class

Adult

Paediatric

Notes

HRZE (isoniazid + rifampicin + pyrazinamide + ethambutol)^[1]

First-line antitubercular fixed-dose combination

Weight-band: 30–37 kg: 2 FDC tabs; 38–54: 3 tabs; 55–69: 4 tabs; ≥70: 5 tabs daily for intensive phase

Weight-band per NTEP paediatric tables

Standard 6-month regimen for most extrapulmonary TB (2HRZE / 4HR). Extended to 9–12 months for CNS, bone, joint, disseminated TB

Pyridoxine (vitamin B6)^[1]

Adjunctive co-prescription

10 mg PO daily during ATT

5–10 mg daily